Association of Serum Melatonin Level with Mild Cognitive Impairment in Type 2 Diabetic Patients: A Cross-Sectional Study
Objectives. Melatonin is an essential neuroendocrine hormone that participates in the regulation of sleep rhythm and cognitive function. This study aimed to determine serum melatonin levels with mild cognitive impairment (MCI) in patients with type 2 diabetes (T2DM). Methods. A total of 247 T2DM pat...
Saved in:
Main Authors: | Jichen Zhang, Jiancan Lu, Hongling Zhu, Xinglu Zhou, Xijuan Wei, Mingjun Gu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2021/5566019 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Elevated Osteopontin Levels in Mild Cognitive Impairment and Alzheimer’s Disease
by: Yuan Sun, et al.
Published: (2013-01-01) -
Cognitive profile in mild cognitive impairment with Lewy bodies
by: Shuai Liu, et al.
Published: (2023-08-01) -
Role of visual function and performance of activities of daily living in cognitive function in patients with mild cognitive impairment: a cross-sectional study
by: Chunhui Zhou, et al.
Published: (2025-02-01) -
Neuropsychiatric symptoms and specific cognitive domains in mild cognitive impairment
by: Lucas Luchesi Barnes, et al.
Published: (2025-01-01) -
Mild Cognitive Impairment and Depressive Symptoms in Elderly Patients with Diabetes: Prevalence, Risk Factors, and Comorbidity
by: Malgorzata Gorska-Ciebiada, et al.
Published: (2014-01-01)